Diabetes Mellitus Type 2NCT00233649

DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines

An observational study of Diabetes Mellitus Type 2 and Crestor, Rosuvastatin, run by AstraZeneca at 222 sites in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

The purpose of this study is to determine in DM II patients the efficacy of Crestor in obtaining the new European LDL cholesterol guidelines. Read more about this study

Who is it for?: Ages 18 to 70 years
Conditions the study is for: Diabetes Mellitus Type 2, Crestor, Rosuvastatin, LDL Cholesterol
How many people: 2,500 participants
Where: 222 sitesNetherlands
Study dates: May 2004to not given
Phase: Observational
Are there results?: None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 18 to 70 years
All sexes
No healthy volunteers
Adult, Older adult

Study population: Diabetes Mellitus Type 2

Who may be able to join

Diabetes Mellitus Type 2, LDL-C > 2,5 mmol/l, no cholesterol lowering medication used last 3 months, starts with Crestor 10 mg, permission to use patient data by AZ

Who cannot join

None listed.

Trial locations and contacts

222 sites in 1 country.

City, postcode or hospital

222 sites in 1 country

Netherlands222 sites

Research Site
's Gravenmoer
Research Site
's-Hertogenbosch
Research Site
Aalten
Research Site
Alkmaar
Research Site
Almelo
Research Site
Alphen aan den Rijn
Research Site
Amersfoort
Research Site
Ammerzoden
Research Site
Amstelveen
Research Site
Amsterdam
Research Site
Amsterdam-Zuidoost
Research Site
Andijk
Research Site
Apeldoorn
Research Site
Arcen
Research Site
Arkel
Research Site
Arnhem
Research Site
Assen
Research Site
Baard
Research Site
Baarle-Nassau
Research Site
Baflo
Research Site
Beek en Donk
Research Site
Benningbroek
Research Site
Bergeijk
Research Site
Bergen op Zoom
Research Site
Best
Research Site
Beverwijk
Research Site
Bilthoven
Research Site
Blaricum
Research Site
Bocholtz
Research Site
Boekel
Research Site
Boxtel
Research Site
Breda
Research Site
Brunssum
Research Site
Budel
Research Site
Burgum
Research Site
Bussum
Research Site
Callantsoog
Research Site
Capelle aan den IJssel
Research Site
Castricum
Research Site
Coevorden
Research Site
Cuijk
Research Site
Damwoude
Research Site
Delft
Research Site
Delfzijl
Research Site
Den Helder
Research Site
Deurne
Research Site
Dieren
Research Site
Dirksland
Research Site
Doesburg
Research Site
Doetinchem
Research Site
Dokkum
Research Site
Doorn
Research Site
Drachten
Research Site
Duiven
Research Site
Echt
Research Site
Ede Gld
Research Site
Eemnes
Research Site
Eersel
Research Site
Egmond aan den Hoef
Research Site
Eibergen
Research Site
Eindhoven
Research Site
Elim
Research Site
Emmeloord
Research Site
Emmen
Research Site
Enkhuizen
Research Site
Enschede
Research Site
Exloo
Research Site
Garderen
Research Site
Geldrop
Research Site
Geleen
Research Site
Goes
Research Site
Goirle
Research Site
Gorinchem
Research Site
Groningen
Research Site
Grootebroek
Research Site
Haarlem
Research Site
Hapert
Research Site
Hardenberg
Research Site
Haren
Research Site
Harskamp
Research Site
Havelte
Research Site
Heerenveen
Research Site
Heerlen
Research Site
Heeswijk-Dinther
Research Site
Heiloo
Research Site
Hellevoetsluis
Research Site
Helmond
Research Site
Hengelo Ov
Research Site
Hillegom
Research Site
Hoogeveen
Research Site
Hoogvliet
Research Site
Hoorn
Research Site
Horst
Research Site
Houten
Research Site
Huizen
Research Site
Hulst
Research Site
IJmuiden
Research Site
Joure
Research Site
Kilder
Research Site
Klazienaveen
Research Site
Koekange
Research Site
Lage Mierde
Research Site
Landgraaf
Research Site
Landsmeer
Research Site
Laren Nh
Research Site
Leek
Research Site
Leersum
Research Site
Leeuwarden
Research Site
Leiden
Research Site
Lemmer
Research Site
Leusden
Research Site
Lichtenvoorde
Research Site
Lieshout
Research Site
Limmen
Research Site
Lisse
Research Site
Lunteren
Research Site
Maarn
Research Site
Maarssen
Research Site
Maastricht
Research Site
Meerlo
Research Site
Melick
Research Site
Meppel
Research Site
Milsbeek
Research Site
Montfoort
Research Site
Moordrecht
Research Site
Musselkanaal
Research Site
Naarden
Research Site
Neede
Research Site
Nibbixwoud
Research Site
Nieuw-Buinen
Research Site
Nieuwdorp Zld
Research Site
Nieuwe Pekela
Research Site
Nieuwegein
Research Site
Nieuwendijk Nb
Research Site
Nijverdal
Research Site
Noord-Scharwoude
Research Site
Noordscheschut
Research Site
Noordwijk Zh
Research Site
Nunspeet
Research Site
Oegstgeest
Research Site
Oldenzaal
Research Site
Oost West en Middelbeers
Research Site
Oosterhout Nb
Research Site
Oss
Research Site
Oud-Beijerland
Research Site
Oude Pekela
Research Site
Oudega Gem Smallingerlnd
Research Site
Oudorp Nh
Research Site
Pijnacker
Research Site
Poeldijk
Research Site
Poortvliet
Research Site
Purmerend
Research Site
Ridderkerk
Research Site
Rijnsburg
Research Site
Rijsbergen
Research Site
Rijssen
Research Site
Rockanje
Research Site
Roosendaal
Research Site
Rotterdam
Research Site
Rozenburg Zh
Research Site
Schoonhoven
Research Site
Sint Willebrord
Research Site
Sint-Oedenrode
Research Site
Sliedrecht
Research Site
Sneek
Research Site
Sommelsdijk
Research Site
Son
Research Site
Spijkenisse
Research Site
Stadskanaal
Research Site
Steenbergen Nb
Research Site
T Zand Nh
Research Site
Ten Boer
Research Site
Ter Aar
Research Site
Terneuzen
Research Site
The Hague
Research Site
Tiel
Research Site
Tilburg
Research Site
Tuitjenhorn
Research Site
Uden
Research Site
Ulft
Research Site
Usquert
Research Site
Utrecht
Research Site
Valkenswaard
Research Site
Veenendaal
Research Site
Veghel
Research Site
Velden
Research Site
Veldhoven
Research Site
Venlo
Research Site
Venray
Research Site
Vlaardingen
Research Site
Vledder
Research Site
Vlijmen
Research Site
Voerendaal
Research Site
Volendam
Research Site
Voorburg
Research Site
Voorhout
Research Site
Voorschoten
Research Site
Vries
Research Site
Vught
Research Site
Waalre
Research Site
Wamel
Research Site
Warmond
Research Site
Warnsveld
Research Site
Weert
Research Site
Westerhaar-vriezenv Wijk
Research Site
Westervoort
Research Site
Wijchen
Research Site
Wildervank
Research Site
Winschoten
Research Site
Winterswijk
Research Site
Wognum
Research Site
Zeewolde
Research Site
Zeist
Research Site
Zevenhuizen Gn
Research Site
Zoetermeer
Research Site
Zuidhorn
Research Site
Zuidlaren
Research Site
Zutphen
Research Site
Zwaag
Research Site
Zwaagwesteinde
Research Site
Zwijndrecht
Research Site
Zwolle

Other trials in Netherlands

About this study

The purpose of this study is to determine in DM II patients the efficacy of Crestor in obtaining the new European LDL cholesterol guidelines.

Conditions: Diabetes Mellitus Type 2, Crestor, Rosuvastatin, LDL Cholesterol, Observational
Medical subject headings: Diabetes Mellitus, Type 2

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

May 2004?

First posted6 Oct 2005 (estimated)
Study startMay 2004

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Other trials for Diabetes Mellitus Type 2Studies of the same condition, open and under way.
More trials run by AstraZenecaThe sponsor's other registered studies.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Observational
Time perspective: Prospective
Enrolment: 2,500 participants

IDs, dates and publications

ClinicalTrials.gov ID: NCT00233649
Sponsor's protocol ID: NL401017
Status last verified: Nov 2010
First submitted: 5 Oct 2005
Last updated: 19 Nov 2010
Results posted: No

Want to know more?

The sponsor has not listed a contact. The official record may have more details.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See locations

Not yet recruitingPhase 3
Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 Diabetes
Type 2 Diabetes
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Not yet recruitingPhase 3
A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
Obesity, Overweight
Not yet recruiting
Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)
Type 2 Diabetes Mellitus (T2D), Obesity (BMI>30)

All Diabetes Mellitus Type 2 trials

Study at a glance

From the registry record, last updated by the sponsor on 19 Nov 2010. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines
ClinicalTrials.gov ID: NCT00233649
Acronym / sponsor ID: NL401017
Conditions: Diabetes Mellitus Type 2, Crestor, Rosuvastatin, LDL Cholesterol, Observational
Study type: Observational
Recruitment status: Completed
Enrolment: 2,500 participants
Lead sponsor: AstraZenecaIndustry (pharma, biotech, devices)
Study start: May 2004
First posted: 6 Oct 2005 (estimated)
Results: Not posted in the source record

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

The purpose of this study is to determine in DM II patients the efficacy of Crestor in obtaining the new European LDL cholesterol guidelines.

Study design

Time perspective: Prospective

Who may qualify

Ages: 18 to 70 years
Sex: All
Healthy volunteers: Not accepted
Age groups: Adult, Older adult
Study population: Diabetes Mellitus Type 2

Key inclusion criteria (1 listed)

Diabetes Mellitus Type 2, LDL-C > 2,5 mmol/l, no cholesterol lowering medication used last 3 months, starts with Crestor 10 mg, permission to use patient data by AZ

Key exclusion criteria (0 listed)

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Primary outcome

Not reported in the source record.

Results and safety

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 19 Nov 2010.

Related trials for Diabetes Mellitus Type 2

Not yet recruitingPhase 3
Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 Diabetes
Type 2 Diabetes
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Not yet recruitingPhase 3
A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
Obesity, Overweight
Not yet recruiting
Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)
Type 2 Diabetes Mellitus (T2D), Obesity (BMI>30)

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

Astra Zeneca study director

AstraZeneca

222 sites in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

An observational study of Diabetes Mellitus Type 2 and Crestor, Rosuvastatin, run by AstraZeneca at 222 sites in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Nov 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 222 sites in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00233649.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Nov 2010; AzTrials last refreshed its copy on 7 Nov 2026.